Multiple Myeloma Clinical Trials

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Verified

Phase 3 Clinical Trial Comparing Iberdomide VS Lenalidomide as Maintenance Therapy Following Autologous Stem Cell Transplant in Participants with Newly Diagn...

EXCALIBER-MAINTENANCE

View Trial

Verified

A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

MONUMENTAL-8

View Trial

Verified

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)

IMPACT

View Trial

Verified

A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma (ADVANCE)

ADVANCE

View Trial

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

BONE MARROW & KIDNEY TRANSPLANT

View Trial

Verified

A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma

DREAMM9

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

PROMISE

View Trial

A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autole...

CARTITUDE-6

View Trial

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...

DRAMMATIC

View Trial

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE ...

EQUATE

View Trial

A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants Wi...

MAJESTEC-7

View Trial

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a ...

TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCE

View Trial

Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2...

FONDO-LOW

View Trial

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

MILESTONE

View Trial

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myelom...

VICD

View Trial

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma

ISATUXIMAB

View Trial

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

SELINEXOR

View Trial

Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...

SUBQ DARATUMUMAB IN ELDERLY PATIENTS

View Trial

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

LOW-DOSE RADIOTHERAPY FOR BONE METASTASES

View Trial

Isatuximab Plus Lenalidomide and Dexamethasone for Frail and/or Much Older Patients With Newly Diagnosed Mu...

ISATUXIMAB IN FRAIL PATIENTS

View Trial

Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial

REACH

View Trial

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...

INVESTIGATIONAL CORD BLOOD UNITS

View Trial

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

CD38-TARGETED IMMUNOPET

View Trial

Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...

CAR T IN PATIENTS WITH RENAL IMPAIRMENT

View Trial

A Phase II Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab for Patients With...

CYBORD PLUS DARATUMUMAB

View Trial

A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma

18F-FLUCICLOVINE PET / CT SCAN

View Trial

MRD-Guided Sequential Therapy For Deep Response in Newly Diagnosed Multiple Myeloma - MASTER-2 Trial

MASTER-2

View Trial

A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Di...

DARA-SVD VS. DARA-RVD

View Trial

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...

PRE AND POST TRANSPLANT ELRANATAMAB

View Trial

Phase 2 Trial of Belantamab Mafodotin Consolidation Treatment in Patients With Multiple Myeloma and MRD Pos...

BELANTAMAB MAFODOTIN CONSOLIDATION

View Trial

Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autolo...

BELANTAMAB MAFODOTIN OR LENALIDOMIDE MAINTENANCE

View Trial

An Attenuated Schedule Dara-RVd Induction for Patients With Newly Diagnosed Multiple Myeloma Who Are Eligib...

DARATUMUMAB COMBINATION INDUCTION

View Trial

An Open-Label, Non-Randomized, Multicenter, Phase II Study to Study the Efficacy of Talquetamab (JNJ-644075...

OPTIMMAL

View Trial

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

MRD-GUIDED ELRANATAMAB MAINTENANCE THERAPY

View Trial

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multip...

ULTRAFRAILMM

View Trial

A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Au...

AMMBITION

View Trial

Phase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesr...

MELPHALAN WITH OR WITHOUT SILTUXIMAB

View Trial

Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for the Treatment of Newly Diagnosed Multiple Myelom...

IDEAL

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

²¹¹AT-OKT10-B10 WITH FLUDARABINE

View Trial

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma (CarMob)

CARMOB

View Trial

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

NK CELL THERAPY WITH BHV-1100

View Trial

Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patient...

LINKER-MM4

View Trial

VitD3 Supplementation in Patients With Multiple Myeloma

VITAMIN D

View Trial

Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...

ITACITINIB

View Trial

Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

PET IMAGING

View Trial

Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...

VENETOCLAX PLUS LENALIDOMIDE

View Trial

Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B

64CU-LLP2A-PET/CT

View Trial

Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)

CHEMOSENSITIVITY STUDY

View Trial

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

TISSUE BANKING

View Trial

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...

MEDULLA

View Trial

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...

NON-CHEMOTHERAPEUTIC INTERVENTIONS

View Trial

Registry for Adults With Plasma Cell Disorders (PCD's)

REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS

View Trial

Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Sym...

AMBIENT LIGHT

View Trial

ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...

ASH RESEARCH COLLABORATIVE DATA HUB

View Trial

The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...

REIKI

View Trial

The Role of the Comprehensive Geriatric Assessment in Elderly Patients With Multiple Myeloma: A Single Cent...

COMPREHENSIVE GERIATRIC ASSESSMENT

View Trial

An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients Wit...

APP SICP

View Trial

Tissue Procurement For Hematolymphoid Conditions

TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION

View Trial

Sleep Apnea in Patients With MGUS and Multiple Myeloma

SLEEP APNEA

View Trial

Testing Two Implementation Strategies in Collecting ePRO Among Multiple Myeloma Patients

EPRO4MM

View Trial

Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For ...

EXERCISE PREHABILITATION

View Trial

cfDNA Assay Multicenter Prospective Observational Validation for Early Cancer Detection, Minimal Residual D...

CAMPERR

View Trial

Blinded Reference Set for Multicancer Early Detection Blood Tests

EARLY DETECTION BLOOD TESTS

View Trial

A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma

PRAGMMATIC

View Trial

Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Tra...

PROACTIVE

View Trial

Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transpl...

CHAPLAIN-DELIVERED MEDITATION

View Trial

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

WU-PE-CGS

View Trial

Pilot Trial of Homebound Stem Cell Transplantation

HOMEBOUND STEM CELL TRANSPLANT

View Trial

Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Trans...

MUSCLE STIMULATION DURING STEM CELL TRANSPLANT

View Trial

Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cel...

PREHABILITATION FEASIBILITY

View Trial

Integrated Actionable Aging Assessment for Cancer Patients Pilot

AGING ASSESSMENT

View Trial

Cancer Moonshot Biobank Research Protocol

CANCER MOONSHOT BIOBANK

View Trial

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

GENETIC STUDIES

View Trial

Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma

BIOMARKER FOR INFECTION RISK

View Trial

Non-Invasive Minimal Residual Disease (MRD) Assessment in Multiple Myeloma Via Functional Imaging and Liqui...

NIRVANA

View Trial

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

CARE-HEME

View Trial

A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Dive...

PREBIOTICS AFTER AUTOLOGOUS STEM CELL TRANSPLANT

View Trial

Prospective, Digitized Dietary Intake Monitoring in Individuals Undergoing Cancer Therapy

DIETARY INTAKE MONITORING

View Trial

The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy

LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS

View Trial

An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors

MOLECULAR PROFILING

View Trial

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogen...

TREATMENT EXPERIENCE OF PATIENTS

View Trial

Implementing a Plant-Based Whole-Foods Meal Delivery Service for Patients Undergoing Autologous Hematopoiet...

PLANT-BASED WHOLE-FOODS MEAL DELIVERY

View Trial

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in P...

EXCALIBER RRMM

View Trial

Verified

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...

SUCCESSOR-1

View Trial

Verified

Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Re...

SUCCESSOR-2

View Trial

Verified

Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...

MONUMENTAL-3

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...

MAGNETISMM-32

View Trial

Verified

A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...

LINKER-MM3

View Trial

Verified

Phase 2, Open-Label Study Evaluating the Use of an Investigational CAR-T Cell therapy in Participants with Multiple Myeloma

CARTITUDE-2

View Trial

Verified

Phase 1B / 2 Study of Selinexor in Combination With Other Treatments for Relapsed/Refractory and Newly Diagnosed Multiple Myeloma.

STOMP

View Trial

Verified

Phase 1B Study Evaluating Elranatamab in Combination with Carfilzomib/Dexamethasone or in Combination with PF-07901801 (maplirpacept) in Relapsed/Refractory ...

MAGNETISMM-20

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...

SELINEXOR

View Trial

Verified

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)

IMPACT

View Trial

Verified

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

DARATUMUMAB COMBINATION THERAPY

View Trial

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

BONE MARROW & KIDNEY TRANSPLANT

View Trial

Verified

Phase 2 Clinical Trial Studying the Safety and Efficacy of bb2121 in Participants with Relapsed and Refractory Multiple Myeloma or Clinical High-Risk Multipl...

KARMMA-2

View Trial

Verified

Personalized Autologous Transplant for Multiple Myeloma

PERSONALIZED AUTOLOGOUS TRANSPLANT

View Trial

Verified

A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function

DREAMM13

View Trial

Verified

A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function

DREAMM12

View Trial

Verified

Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge)

SELVEDGE

View Trial

Verified

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

BELANTAMAB MAFADOTIN MAINTENANCE THERAPY

View Trial

Verified

A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants With Relapsed an...

CA088-1005

View Trial

Verified

A Phase 1 Randomized, Open Label Pharmacokinetic Comparability Study Comparing Pre- and Post-change Teclistamab in Participants With Relapsed/Refractory Mult...

MAJESTEC-10

View Trial

Verified

PTSD Mobile App for Cancer Survivors

PTSD MOBILE APP

View Trial

Verified

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

STOPPING MAINTENANCE THERAPY

View Trial

Verified

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy (PEACE)

PEACE

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

PROMISE

View Trial

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...

DRAMMATIC

View Trial

A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in C...

MONUMENTAL-6

View Trial

A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies...

CERVINO

View Trial

A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Ver...

IMMAGINE-3

View Trial

Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2...

FONDO-LOW

View Trial

A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of BMS-986393, a GP...

QUINTESSENTIAL-2

View Trial

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-c...

RADIATION AFTER BCMA CAR-T THERAPY

View Trial

Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

ISATUXIMAB DURING STEM CELL TRANSPLANT

View Trial

Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma

IMMAGINE-1

View Trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

IMPEDE

View Trial

Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple...

BELANTAMAB MAFODOTIN

View Trial

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...

SELINEXOR

View Trial

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

LEFLUNOMIDE

View Trial

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

LOW-DOSE RADIOTHERAPY FOR BONE METASTASES

View Trial

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...

ISA-CAPED

View Trial

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...

INVESTIGATIONAL CORD BLOOD UNITS

View Trial

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

CD38-TARGETED IMMUNOPET

View Trial

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...

D-CLAPD

View Trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

UCB TRANSPLANT WITH MYELOABLATIVE PREP

View Trial

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...

BELANTAMAB MAFODOTIN

View Trial

Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients...

IBER-KDD

View Trial

Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...

CAR T IN PATIENTS WITH RENAL IMPAIRMENT

View Trial

A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...

ISABELA

View Trial

Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...

ISATUXIMAB COMBINATION THERAPY

View Trial

Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple...

TECLISTAMAB

View Trial

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...

MYELOABLATIVE ALLO STEM CELL TRANSPLANT

View Trial

Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...

PERSONALIZED NATURAL KILLER CELL THERAPY

View Trial

Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma

TALQUETAMAB CONSOLIDATION AFTER BCMA CAR-T

View Trial

A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma

18F-FLUCICLOVINE PET / CT SCAN

View Trial

IBEX: Phase 2 Trial of Iberdomide + SQ Daratumumab as Post-Autologous Stem Cell Transplant Maintenance Ther...

IBEX

View Trial

Phase 2 Trial of Belantamab Mafodotin Consolidation Treatment in Patients With Multiple Myeloma and MRD Pos...

BELANTAMAB MAFODOTIN CONSOLIDATION

View Trial

A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) a...

CRS AND ICANS TREATMENT

View Trial

A Study of Elranatamab Management With Outpatient and Intermittent Dosing in Relapsed/Refractory Multiple M...

EMBRACE

View Trial

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic He...

ISATUXIMAB AFTER ALLOGENEIC STEM CELL TRANSPLANT

View Trial

Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Respon...

NIVOLUMAB POST TREATMENT WITH IDE-CEL

View Trial

Phase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesr...

MELPHALAN WITH OR WITHOUT SILTUXIMAB

View Trial

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multip...

RADIOIMMUNOTHERAPY

View Trial

A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzom...

BGB-11417

View Trial

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...

APG-2575

View Trial

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

HDP-101

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

²¹¹AT-OKT10-B10 WITH FLUDARABINE

View Trial

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

TASQUINIMOD

View Trial

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

APG-2575

View Trial

Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...

MONUMENTAL-1

View Trial

Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)

TACTAM

View Trial

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma (CarMob)

CARMOB

View Trial

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)

P-BCMA-ALLO1

View Trial

A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Mul...

IBERDOMIDE COMBINATION THERAPY

View Trial

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

SELINEXOR

View Trial

A Phase Ib Clinical Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A...

BCMA CAR-T CELL INJECTION (CT103A)

View Trial

VitD3 Supplementation in Patients With Multiple Myeloma

VITAMIN D

View Trial

Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...

ITACITINIB

View Trial

Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma

IXAZOMIB COMBINATION THERAPY

View Trial

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antige...

AUTOLOGOUS STEM CELL TRANSPLANT POST CAR-T

View Trial

Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

PET IMAGING

View Trial

A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection An...

REDIRECTT-1

View Trial

Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...

ELOTUZUMAB COMBINATION THERAPY

View Trial

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Le...

LP-118

View Trial

Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...

VENETOCLAX PLUS LENALIDOMIDE

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

Phase I/II Trial of Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma

MEZIGDOMIDE PLUS IXAZOMIB

View Trial

A Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Administration o...

STAR-LLD

View Trial

Remote Monitoring With Health-Coaching for Lifestyle Changes in Older Patients With Multiple Myeloma

REMOTE MONITORING OF OLDER PATIENTS

View Trial

A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Re...

MAGNETISMM-30

View Trial

A Phase I/II Study to Assess the Safety and Tolerability of the Combination of Oral ON 123300 (Narazaciclib...

ON 123300 (NARAZACICLIB) AND DEXAMETHASONE

View Trial

A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Tre...

TALQUETAMAB WITH IBERDOMIDE

View Trial

A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and...

ORICAR-017 - RIGEL STUDY

View Trial

Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants Wit...

JNJ-79635322

View Trial

Phase 1-2 UMBRELLA Trial Evaluating Isatuximab With or Without Dexamethasone in Combination With Novel Agen...

ISATUXIMAB IN COMBINATION WITH NOVEL AGENTS

View Trial

Multi-institutional Prospective Pilot Study of Radiology Evaluation of Acute Leukemia Infiltration analyZed...

REALIZE

View Trial

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...

SCOPE

View Trial

A Pilot Study of the Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Recon...

CYT107

View Trial

A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedul...

RADIATION + TALQUETAMAB FOR EXTRAMEDULLARY DISEASE

View Trial

Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B

64CU-LLP2A-PET/CT

View Trial

Phase 1 Trial of SX-682, a CXCR 1/2 Inhibitor, in Combination With Standard of Care Treatment in Patients W...

SX-682

View Trial

Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)

CHEMOSENSITIVITY STUDY

View Trial

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

TISSUE BANKING

View Trial

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...

MEDULLA

View Trial

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab

DIGITAL HEALTH COACHING

View Trial

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MR...

HEME-20

View Trial

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...

NON-CHEMOTHERAPEUTIC INTERVENTIONS

View Trial

Registry for Adults With Plasma Cell Disorders (PCD's)

REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS

View Trial

Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Sym...

AMBIENT LIGHT

View Trial

ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...

ASH RESEARCH COLLABORATIVE DATA HUB

View Trial

The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...

REIKI

View Trial

The Prospective Collection, Storage and Reporting of Data on Patients

PATIENT REGISTRY: UNDERGOING STEM CELL TRANSPLANT

View Trial

An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients Wit...

APP SICP

View Trial

Tissue Procurement For Hematolymphoid Conditions

TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION

View Trial

A Randomized Pilot Study of Yoga Intervention in Patients With Multiple Myeloma on Active Therapy

WEEKLY YOGA

View Trial

Randomized Controlled Trial of a Psychosocial Mobile Application (THRIVE-M) for Patients Living With Multip...

THRIVE-M

View Trial

Sleep Apnea in Patients With MGUS and Multiple Myeloma

SLEEP APNEA

View Trial

Testing Two Implementation Strategies in Collecting ePRO Among Multiple Myeloma Patients

EPRO4MM

View Trial

Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Diso...

IDENTIFYING BARRIERS TO CELLULAR THERAPY

View Trial

Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For ...

EXERCISE PREHABILITATION

View Trial

The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A ...

IMPACT OF NON-PROFIT ON PATIENT OUTCOMES & CARE

View Trial

Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Tra...

PROACTIVE

View Trial

Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transpl...

CHAPLAIN-DELIVERED MEDITATION

View Trial

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

WU-PE-CGS

View Trial

Pilot Trial of Homebound Stem Cell Transplantation

HOMEBOUND STEM CELL TRANSPLANT

View Trial

Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Trans...

MUSCLE STIMULATION DURING STEM CELL TRANSPLANT

View Trial

Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cel...

PREHABILITATION FEASIBILITY

View Trial

Cancer Moonshot Biobank Research Protocol

CANCER MOONSHOT BIOBANK

View Trial

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

GENETIC STUDIES

View Trial

Cancer Sequencing Guided Personalized and Precision Medicine Platform in Multiple Myeloma

PRECISION MEDICINE STUDY

View Trial

Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma

BIOMARKER FOR INFECTION RISK

View Trial

Non-Invasive Minimal Residual Disease (MRD) Assessment in Multiple Myeloma Via Functional Imaging and Liqui...

NIRVANA

View Trial

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

CARE-HEME

View Trial

A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Dive...

PREBIOTICS AFTER AUTOLOGOUS STEM CELL TRANSPLANT

View Trial

Prospective, Digitized Dietary Intake Monitoring in Individuals Undergoing Cancer Therapy

DIETARY INTAKE MONITORING

View Trial

The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy

LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS

View Trial

An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors

MOLECULAR PROFILING

View Trial

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogen...

TREATMENT EXPERIENCE OF PATIENTS

View Trial

Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial

HEME HOSPICE - HOME TRANSFUSION PROGRAM

View Trial

Implementing a Plant-Based Whole-Foods Meal Delivery Service for Patients Undergoing Autologous Hematopoiet...

PLANT-BASED WHOLE-FOODS MEAL DELIVERY

View Trial

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...

SUCCESSOR-1

View Trial

Verified

Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Re...

SUCCESSOR-2

View Trial

Verified

Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...

MONUMENTAL-3

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...

MAGNETISMM-32

View Trial

Verified

A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...

LINKER-MM3

View Trial

Verified

Phase 2, Open-Label Study Evaluating the Use of an Investigational CAR-T Cell therapy in Participants with Multiple Myeloma

CARTITUDE-2

View Trial

Verified

Phase 2 Study of BMS-986393, a GPRC5D-directed CART-Cell Therapy, in Participants with Relapsed or Refractory Multiple Myeloma

QUINTESSENTIAL

View Trial

Verified

A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

MONUMENTAL-8

View Trial

Verified

Phase 1/2 Clinical Trial Evaluating the Safety, Effectiveness and Best Dose of Elranatamab Combined with Different Anti-Cancer Therapies in Participants with...

MAGNETISMM-4

View Trial

Verified

Phase 1B / 2 Study of Selinexor in Combination With Other Treatments for Relapsed/Refractory and Newly Diagnosed Multiple Myeloma.

STOMP

View Trial

Verified

Phase 1B Study Evaluating Elranatamab in Combination with Carfilzomib/Dexamethasone or in Combination with PF-07901801 (maplirpacept) in Relapsed/Refractory ...

MAGNETISMM-20

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...

SELINEXOR

View Trial

Verified

A Study to See if Anti-BCMA CAR T-Cell Therapy Can Be Made from People with Multiple Myeloma Who Have Had a Stem Cell Transplant

IDE-CEL POST HEMATOPOIETIC CELL TRANSPLANT

View Trial

Verified

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)

IMPACT

View Trial

Verified

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

MONUMENTAL-1

View Trial

Verified

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

DARATUMUMAB COMBINATION THERAPY

View Trial

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

BONE MARROW & KIDNEY TRANSPLANT

View Trial

Verified

Phase 2 Clinical Trial Studying the Safety and Efficacy of bb2121 in Participants with Relapsed and Refractory Multiple Myeloma or Clinical High-Risk Multipl...

KARMMA-2

View Trial

Verified

Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma

VENETOCLAX AND TOCILIZUMAB FOR T(11;14)

View Trial

Verified

TriPRIL CAR T Cells in Multiple Myeloma

TRIPRIL CAR T

View Trial

Verified

Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy

SELINEXOR FOR LENALIDOMIDE-REFRACTORY PATIENTS

View Trial

Verified

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

KPG-818

View Trial

Verified

Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma

CAR138 T-CELLS

View Trial

Verified

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

RUXOLITINIB

View Trial

Verified

A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function

DREAMM13

View Trial

Verified

A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function

DREAMM12

View Trial

Verified

Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge)

SELVEDGE

View Trial

Verified

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

BELANTAMAB MAFADOTIN MAINTENANCE THERAPY

View Trial

Verified

A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants With Relapsed an...

CA088-1005

View Trial

Verified

A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or R...

BMS-986453

View Trial

Verified

A Phase 1 Randomized, Open Label Pharmacokinetic Comparability Study Comparing Pre- and Post-change Teclistamab in Participants With Relapsed/Refractory Mult...

MAJESTEC-10

View Trial

Verified

PTSD Mobile App for Cancer Survivors

PTSD MOBILE APP

View Trial

Verified

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

STOPPING MAINTENANCE THERAPY

View Trial

Verified

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy (PEACE)

PEACE

View Trial

Verified

Platform Study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Mu...

DREAMM5

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

PROMISE

View Trial

Expanded Access Request Program for Belantamab Mafodotin in Multiple Myeloma

EXPANDED ACCESS REQUEST FOR BELANTAMAB MAFODOTIN

View Trial

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duratio...

DRAMMATIC

View Trial

A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in C...

MONUMENTAL-6

View Trial

A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies...

CERVINO

View Trial

A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Ver...

IMMAGINE-3

View Trial

Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2...

FONDO-LOW

View Trial

A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of BMS-986393, a GP...

QUINTESSENTIAL-2

View Trial

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-c...

RADIATION AFTER BCMA CAR-T THERAPY

View Trial

Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma

IMMAGINE-1

View Trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

IMPEDE

View Trial

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...

SELINEXOR

View Trial

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

LEFLUNOMIDE

View Trial

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

LOW-DOSE RADIOTHERAPY FOR BONE METASTASES

View Trial

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...

ISA-CAPED

View Trial

Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multipl...

AMBUSH

View Trial

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...

INVESTIGATIONAL CORD BLOOD UNITS

View Trial

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

CD38-TARGETED IMMUNOPET

View Trial

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...

D-CLAPD

View Trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

UCB TRANSPLANT WITH MYELOABLATIVE PREP

View Trial

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...

BELANTAMAB MAFODOTIN

View Trial

Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy for Relapsed/Refractory Multipl...

CEVOSTAMAB AFTER CAR-T CELL THERAPY

View Trial

A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma

BELANTAMAB MAFODOTIN IN THE COMMUNITY SETTING

View Trial

Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients...

IBER-KDD

View Trial

Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...

CAR T IN PATIENTS WITH RENAL IMPAIRMENT

View Trial

A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...

ISABELA

View Trial

Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...

ISATUXIMAB COMBINATION THERAPY

View Trial

Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple...

TECLISTAMAB

View Trial

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...

MYELOABLATIVE ALLO STEM CELL TRANSPLANT

View Trial

Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...

PERSONALIZED NATURAL KILLER CELL THERAPY

View Trial

Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma

TALQUETAMAB CONSOLIDATION AFTER BCMA CAR-T

View Trial

A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma

18F-FLUCICLOVINE PET / CT SCAN

View Trial

IBEX: Phase 2 Trial of Iberdomide + SQ Daratumumab as Post-Autologous Stem Cell Transplant Maintenance Ther...

IBEX

View Trial

Phase II Trial for Evaluation of Alternate Doses and Dosing Schedules of Belantamab Mafodotin in Triple-Cla...

DIFFERENT DOSES OF BELANTAMAB MAFODOTIN

View Trial

A Phase 2 Study of Elranatamab as Consolidation After Idecabtagene Vicleucel in Relapsed Refractory Multipl...

ELRANATAMAB AS CONSOLIDATION

View Trial

Phase II Trial of Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to Treatment With Teclistamab ...

SILTUXIMAB

View Trial

Phase 2 Trial of Belantamab Mafodotin Consolidation Treatment in Patients With Multiple Myeloma and MRD Pos...

BELANTAMAB MAFODOTIN CONSOLIDATION

View Trial

Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multip...

IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T

View Trial

A Phase 2 Randomized, Multi-center Study of GEO-CMO4S1 (SARS-CoV-2 Vaccine) Versus mRNA SARS-CoV-2 Vaccine ...

GEO-CM04S1 VS MRNA SARS-COV-2 VACCINE

View Trial

A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) a...

CRS AND ICANS TREATMENT

View Trial

A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Re...

AUTOLOGOUS T-CELLS

View Trial

A Study of Elranatamab Management With Outpatient and Intermittent Dosing in Relapsed/Refractory Multiple M...

EMBRACE

View Trial

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic He...

ISATUXIMAB AFTER ALLOGENEIC STEM CELL TRANSPLANT

View Trial

Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Respon...

NIVOLUMAB POST TREATMENT WITH IDE-CEL

View Trial

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multip...

RADIOIMMUNOTHERAPY

View Trial

Adoptive Transfer of MUC1 Activated T Cells for the Treatment of MUC1 Positive Recurrent or Refractory Mult...

MUC1 ACTIVATED T CELLS

View Trial

A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzom...

BGB-11417

View Trial

Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma

BELANTAMAB MAFODOTIN AND ELOTUZUMAB

View Trial

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...

APG-2575

View Trial

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

HDP-101

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

²¹¹AT-OKT10-B10 WITH FLUDARABINE

View Trial

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Mul...

CEMSIDOMIDE (CFT7455)

View Trial

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

TASQUINIMOD

View Trial

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

APG-2575

View Trial

High Dose Ascorbic Acid for Plasma Cell Disorders

HIGH-DOSE ASCORBIC ACID

View Trial

CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Mult...

CS1-CAR T CELLS

View Trial

Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...

MONUMENTAL-1

View Trial

Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)

TACTAM

View Trial

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)

P-BCMA-ALLO1

View Trial

LMY-920 for Treatment of Relapsed or Refractory Myeloma (LMY-920-002)

LMY-920

View Trial

A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Mul...

IBERDOMIDE COMBINATION THERAPY

View Trial

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

SELINEXOR

View Trial

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

MMSET INHIBITOR

View Trial

A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy...

CAMMOUFLAGE

View Trial

A Phase Ib Clinical Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A...

BCMA CAR-T CELL INJECTION (CT103A)

View Trial

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed...

ABBV-383

View Trial

VitD3 Supplementation in Patients With Multiple Myeloma

VITAMIN D

View Trial

Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of I...

ITACITINIB

View Trial

Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma

IXAZOMIB COMBINATION THERAPY

View Trial

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antige...

AUTOLOGOUS STEM CELL TRANSPLANT POST CAR-T

View Trial

Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

PET IMAGING

View Trial

A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection An...

REDIRECTT-1

View Trial

A Phase 1b/2 Study of GC012F, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell ...

GCO12F CAR-T

View Trial

Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...

ELOTUZUMAB COMBINATION THERAPY

View Trial

Phase I Study of BCMA-TGF-BETA Insensitive Armored CAR T Cells in Patients With Relapsed and/or Refractory ...

BCMA-TGF-BETA INSENSITIVE ARMORED CAR T CELLS

View Trial

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Le...

LP-118

View Trial

Phase 1 Study of Lintivirally Transduced T Cells Engineered to Contain Anti-CD38 Linked to TCRζ and 4-1BB S...

CART 38

View Trial

Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...

VENETOCLAX PLUS LENALIDOMIDE

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

A Phase 1 Study of Mezigdomide (CC-92480) and Dexamethasone Post Idecabtagene Vicleucel in Relapsed Multipl...

MEZIGDOMIDE POST ABECMA TREATMENT

View Trial

Phase I/II Trial of Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma

MEZIGDOMIDE PLUS IXAZOMIB

View Trial

A Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Administration o...

STAR-LLD

View Trial

Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patien...

BELUMOSUDIL MESYLATE

View Trial

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory M...

AZD0305

View Trial

Phase 1/2 Study of IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Ad...

IDP-023

View Trial

A Phase 1 First-in-human Dose-escalation and Dose-expansion Study of BMF-219, an Oral Covalent Menin Inhibi...

BMF-219

View Trial

Remote Monitoring With Health-Coaching for Lifestyle Changes in Older Patients With Multiple Myeloma

REMOTE MONITORING OF OLDER PATIENTS

View Trial

Phase 1 Dose-Escalation and Dose-Expansion Study of the Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in S...

WS-CART-CS1

View Trial

A Phase Ib Study of TGFbi NK Cells and Isatuximab for Myeloma Relapsed/Refractory to BCMA Targeting Therapy

TGFBI NK CELLS

View Trial

A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Re...

MAGNETISMM-30

View Trial

Phase I/II Trial of Cord Blood-derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Recepto...

NY-ESO-1 TCR/IL-15 NK

View Trial

Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

DC15-MM-01

View Trial

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

HIGH DOSE ASCORBIC ACID W/ MELPHALAN

View Trial

A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Tre...

TALQUETAMAB WITH IBERDOMIDE

View Trial

A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and...

ORICAR-017 - RIGEL STUDY

View Trial

Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants Wit...

JNJ-79635322

View Trial

Phase 1-2 UMBRELLA Trial Evaluating Isatuximab With or Without Dexamethasone in Combination With Novel Agen...

ISATUXIMAB IN COMBINATION WITH NOVEL AGENTS

View Trial

Multi-institutional Prospective Pilot Study of Radiology Evaluation of Acute Leukemia Infiltration analyZed...

REALIZE

View Trial

Phase Ib Trial of Low-Dose Selinexor (KPT-330) in Combination With Choline Salicylate (CS) for the Treatmen...

SELINEXOR WITH CHOLINE SALICYLATE

View Trial

A Phase 1b, Dose Escalation/Dose Expansion, Multicenter, Open-Label Study to Assess the Safety and Tolerabi...

OPN-662

View Trial

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

ELOTUZUMAB + IBERDOMIDE POST ABECMA

View Trial

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...

SCOPE

View Trial

Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell My...

ATRA

View Trial

A Pilot Study of the Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Recon...

CYT107

View Trial

A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally...

QXL138AM

View Trial

A Multicenter, Phase 1b, Open-label Study of ABBV-383 Administered Subcutaneously in Subjects With Relapsed...

ABBV-383

View Trial

A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedul...

RADIATION + TALQUETAMAB FOR EXTRAMEDULLARY DISEASE

View Trial

Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B

64CU-LLP2A-PET/CT

View Trial

A Phase 1b Trial of Teclistamab in Combination With Iberdomide for Relapsed/Refractory Multiple Myeloma

TECVAYLI

View Trial

Phase 1 Trial of SX-682, a CXCR 1/2 Inhibitor, in Combination With Standard of Care Treatment in Patients W...

SX-682

View Trial

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With ...

HIGH THROUGHPUT DRUG SENSITIVITY AND GENOMICS

View Trial

Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)

CHEMOSENSITIVITY STUDY

View Trial

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

TISSUE BANKING

View Trial

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities (MED...

MEDULLA

View Trial

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab

DIGITAL HEALTH COACHING

View Trial

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MR...

HEME-20

View Trial

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...

NON-CHEMOTHERAPEUTIC INTERVENTIONS

View Trial

Registry for Adults With Plasma Cell Disorders (PCD's)

REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS

View Trial

Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Sym...

AMBIENT LIGHT

View Trial

ASH Research Collaborative Data Hub Protocol: A Multi-Center Data Hub of Individuals Living With Hematologi...

ASH RESEARCH COLLABORATIVE DATA HUB

View Trial

The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Reperto...

REIKI

View Trial

The Prospective Collection, Storage and Reporting of Data on Patients

PATIENT REGISTRY: UNDERGOING STEM CELL TRANSPLANT

View Trial

An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients Wit...

APP SICP

View Trial

Tissue Procurement For Hematolymphoid Conditions

TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION

View Trial

A Randomized Pilot Study of Yoga Intervention in Patients With Multiple Myeloma on Active Therapy

WEEKLY YOGA

View Trial

Randomized Controlled Trial of a Psychosocial Mobile Application (THRIVE-M) for Patients Living With Multip...

THRIVE-M

View Trial

Sleep Apnea in Patients With MGUS and Multiple Myeloma

SLEEP APNEA

View Trial

Testing Two Implementation Strategies in Collecting ePRO Among Multiple Myeloma Patients

EPRO4MM

View Trial

Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Diso...

IDENTIFYING BARRIERS TO CELLULAR THERAPY

View Trial

Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For ...

EXERCISE PREHABILITATION

View Trial

The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A ...

IMPACT OF NON-PROFIT ON PATIENT OUTCOMES & CARE

View Trial

Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Tra...

PROACTIVE

View Trial

Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transpl...

CHAPLAIN-DELIVERED MEDITATION

View Trial

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

WU-PE-CGS

View Trial

Pilot Trial of Homebound Stem Cell Transplantation

HOMEBOUND STEM CELL TRANSPLANT

View Trial

Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Trans...

MUSCLE STIMULATION DURING STEM CELL TRANSPLANT

View Trial

Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cel...

PREHABILITATION FEASIBILITY

View Trial

Cancer Moonshot Biobank Research Protocol

CANCER MOONSHOT BIOBANK

View Trial

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

GENETIC STUDIES

View Trial

Cancer Sequencing Guided Personalized and Precision Medicine Platform in Multiple Myeloma

PRECISION MEDICINE STUDY

View Trial

Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma

BIOMARKER FOR INFECTION RISK

View Trial

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

CARE-HEME

View Trial

A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Dive...

PREBIOTICS AFTER AUTOLOGOUS STEM CELL TRANSPLANT

View Trial

Prospective, Digitized Dietary Intake Monitoring in Individuals Undergoing Cancer Therapy

DIETARY INTAKE MONITORING

View Trial

The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy

LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS

View Trial

An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors

MOLECULAR PROFILING

View Trial

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogen...

TREATMENT EXPERIENCE OF PATIENTS

View Trial

Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial

HEME HOSPICE - HOME TRANSFUSION PROGRAM

View Trial

Implementing a Plant-Based Whole-Foods Meal Delivery Service for Patients Undergoing Autologous Hematopoiet...

PLANT-BASED WHOLE-FOODS MEAL DELIVERY

View Trial

Smoldering Myeloma

The following is a listing of clinical trials for patients with Smoldering Myeloma.

Verified

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

IBERDOMIDE

View Trial

Verified

A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma

BELANTAMAB MAFODOTIN

View Trial

Verified

PTSD Mobile App for Cancer Survivors

PTSD MOBILE APP

View Trial

Verified

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

View Trial

Verified

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

View Trial

Verified

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Mult...

NUTRIVENTION3

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

PROMISE

View Trial

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering ...

DETER-SMM

View Trial

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate...

CURCUMIN AND PIPERINE

View Trial

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

IMMUNO-PRISM

View Trial

DARA RVD For High Risk SMM

PRISM

View Trial

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

View Trial

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

CAR-PRISM

View Trial

Teclistamab or Talquetamab in Combination With Daratumumab SC for High-Risk Smoldering Myeloma: A Clinical ...

REVIVE

View Trial

Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopat...

LINKER-MGUS1

View Trial

Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)

TACTAM

View Trial

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precurso...

TRANSFORMM

View Trial

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

ORIGIN STUDY

View Trial

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

TISSUE BANKING

View Trial

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients W...

NON-CHEMOTHERAPEUTIC INTERVENTIONS

View Trial

PROFAST Intervention in Precursor Multiple Myeloma

PROFAST

View Trial

Registry for Adults With Plasma Cell Disorders (PCD's)

REGISTRY FOR ADULTS WITH PLASMA CELL DISORDERS

View Trial

Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The ...

MULTIPLE MYELOMA BIOREPOSITORY

View Trial

Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progre...

PCROWD

View Trial

Microbial Changes in Response to a Plant Based Diet and/or Supplements in SMM Patients: A National Multi-Ar...

SUPPLEMENTS OR PLANT-BASED DIET FOR SMM PATIENTS

View Trial

Sleep Apnea in Patients With MGUS and Multiple Myeloma

SLEEP APNEA

View Trial

Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

SPOTLIGHT

View Trial

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

AMYLOIDOSIS SCREENING

View Trial

Monoclonal Gammopathy of Undetermined Significance (MGUS)

The following is a listing of clinical trials for patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).

Verified

Rifaximin in Patients With Monoclonal Gammopathy

RIFAXIMIN

View Trial

Verified

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

View Trial

Verified

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

View Trial

Verified

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Mult...

NUTRIVENTION3

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Multiple Myeloma

Clinical Trials

We believe...

(888) 828-2206

Clinical Trials